TRU3D™ TISSUE ANALYSIS
The Next Dimension
in Tissue Analysis
Are you involved in preclinical drug development?
Segmentation and classification of tonsil tissue prepared by the CLARITY method
More cost effective versus gold standard 2D thin section methods, representing contiguous and significantly more meaningful biological data
Bringing CLARITY to Preclinical Drug Development Programs.
ClearLight Biotechnologies is working with pharmaceutical, biotechnology, and academic researchers to reduce the cost and failure rates of potential drug candidates during the drug development process.
“CLARITY is powerful. It will enable researchers to study neurological diseases and disorders, focusing on diseased or damaged structures without losing a global perspective. That’s something we’ve never before been able to do in three dimensions.” Francis Collins, Director of the National Institutes of Health (NIH)
CLARITY Advantages:
- More biologically representative analysis of drug mechanism of action by analyzing 3D tissue
- Ability to determine tissue relationships in 3D
- Co-development of biomarkers (CDx) linked to prognosis and prediction
- Workflow efficiency: Efficient and more cost effective than 2D gold standard FFPE
- Can store processed whole tissue for future analysis
- Compatible with previously frozen, fresh, formalin-fixed, and FFPE tissue
ClearLight Biotechnologies Collaborative Custom Lab Services Include:
- CLARITY tissue clearing & immunostaining
- 3D imaging (multiplexed fluorescence)
- True 3D tissue analysis in 3D
Let's Work Together
Do you want to escape the limitations of traditional gold standard FFPE analysis? Then you are ready to explore Tru3D™ Tissue Analysis in 3D for your drug development programs.
Call (408) 329-7769 or fill out the form below.
